POU5F1B is responsible for the acquired resistance to dabrafenib in papillary thyroid cancer cells with the BRAF V600E mutation
Article in Endocrine (August 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Endocrine (August 2024)
Article in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (June 2024)
Article in Frontiers in Oncology (March 2024)